Close
Open
Share on Facebook
Twitter
Email
 
Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

COVID-19 Resources »      Vaccine Update »      Visitor Policy »

Menu
Search
Menu
Search
  • Doctors, Clinics & Locations, Conditions & Treatments
  • Patients & Visitors
  • MyHealth
  • Billing
  • Insurance
  • Medical Records
  • Support Groups
  • Financial Assistance
  • COVID-19 Resource Center
  • Locations and Parking
  • Visitor Policy
  • Hospital Check-in
  • Video Visits
  • International Patients
  • Contact Us
View All Information for Patients & Visitors »
We are available to assist you 24/7.
650-498-3333
GuestServices@stanfordhealthcare.org


View the changes to our visitor policy »

 

View information for Guest Services »

New to MyHealth?

Manage Your Care From Anywhere.

Access your health information from any device with MyHealth.  You can message your clinic, view lab results, schedule an appointment, and pay your bill.

ALREADY HAVE AN ACCESS CODE?

Activate Account

DON'T HAVE AN ACCESS CODE?

Create a New Account

NEED MORE DETAILS?

Learn More about MyHealth »
Learn More about Video Visits »

MyHealth for Mobile

Get the iPhone MyHealth app »
Get the Android MyHealth app »

WELCOME BACK

Forgot Username or Password?
Need Help?

Clear

Myeloproliferative Neoplasms

  • About
  • About
Overview
Types
Overview
Types

Myeloproliferative Neoplasms (MPNs)

Myeloproliferative disorders are a group of rare illnesses that cause blood cells in the bone marrow, including red blood cells, white blood cells, and platelets, to grow and develop abnormally.

Myeloproliferative disorders occur when the body produces too many of one or more types of blood cells. However, the reason for this remains unknown. Researchers believe that genetics and/or the environment may play a role in the development of these disorders.

Myeloproliferative disorders are serious medical conditions. Complications of these disorders may be fatal. A person's survival rate depends on the type of myeloproliferative disorder he/she has, as well as the severity of his/her illness.

Although there is no cure for myeloproliferative disorders, treatment may help patients live several years after they are diagnosed.

Previous Section Next Section

INTERESTED IN AN ONLINE SECOND OPINION?

The Stanford Medicine Online Second Opinion program offers you easy access to our world-class doctors. It’s all done remotely and you don’t have to visit our hospital or one of our clinics for this service. You don’t even need to leave home!

Visit our online second opinion page to learn more.

Clinical Trials for Myeloproliferative Neoplasms

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Open Trials Closed Trials
KRT-232 Versus Best Available Therapy for the Treatment of Subjects With Myelofibrosis Who Are Relapsed or Refractory to JAK Inhibitor Treatment Myeloproliferative Neoplasms
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies Any Cancer or Solid Tumor, Chronic Lymphocytic Leukemia (CLL), Myelodysplastic Syndromes (MDS)
(PATHFINDER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, in Patients With Advanced Systemic Mastocytosis Myeloproliferative Neoplasms
A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Myeloid/Lymphoid Neoplasms With FGFR1 Rearrangement - (FIGHT-203) Myeloproliferative Neoplasms
Clinical Trials View All »

Clinics for Myeloproliferative Neoplasms

  • Stanford Cancer Center Palo Alto
    650-498-6000
  • Cancer Center in South Bay
    833-444-7622
  • Hematology Program
    650-498-6000

Myeloproliferative Neoplasms
Overproduction of normal blood cell types by bone marrow is called myeloproliferative neoplasms (MPN). Cell accummulation impedes circulatory and immunity function.
Myeloproliferative Neoplasms

Stanford Cancer Center Palo Alto
650-498-6000
Cancer Center in South Bay
833-444-7622
Hematology Program
650-498-6000

Types
Related Story

  • Find a Doctor
  • Find Conditions & Treatments
  • Find a Stanford clinic
  • For Patients & Visitors
  • Billing
  • Protections Against Surprise Medical Bills
  • Insurance
  • Hospital Check-in
  • Contact Us
  • Video Visits
  • Send a Greeting Card
  • Get a Second Opinion
  • COVID-19 Resource Center
  • Behavioral Standards
  • Make a Gift
  • About Us
  • Quality & Safety
  • Annual Report
  • 300 Pasteur Drive Renewal Program
  • Stanford Health Care Now
  • For Healthcare Professionals
  • Referring Physicians
  • Nursing
  • Allied Healthcare Professionals
First Responders
  • Newsroom
  • Careers
  • Volunteering
  • Vendors
  • Stanford Medicine Partners
  • Stanford Health Care Tri-Valley
  • Stanford Medicine
  • Stanford Medicine Children's Health
  • Stanford University
  • Legal
  • Privacy
  • Code of Conduct
  • |   Notice of Nondiscrimination      ©2022 Stanford Health Care. All Rights Reserved
Home
Close
Doctors
Clinics & Locations
Conditions & Treatments
Clinical Trials
MyHealth Login

Patients & Visitors
Billing
Insurance
Financial Assistance
Medical Records
Contact Us
Video Visits
Get a Second Opinion
COVID-19 Resource Center
Healthcare Professionals
Referring Physicians
Nursing
Allied Healthcare
About Us
Quality & Safety
Careers
Newsroom
Make a Donation
Stanford Health Care Now
Close